JPS6323972B2 - - Google Patents
Info
- Publication number
- JPS6323972B2 JPS6323972B2 JP54104852A JP10485279A JPS6323972B2 JP S6323972 B2 JPS6323972 B2 JP S6323972B2 JP 54104852 A JP54104852 A JP 54104852A JP 10485279 A JP10485279 A JP 10485279A JP S6323972 B2 JPS6323972 B2 JP S6323972B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- paramecium
- fraction
- molecular weight
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000284 extract Substances 0.000 claims description 35
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 29
- 229920000858 Cyclodextrin Polymers 0.000 claims description 28
- 241000223785 Paramecium Species 0.000 claims description 22
- 230000036541 health Effects 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 238000005194 fractionation Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000019789 appetite Nutrition 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000223786 Paramecium caudatum Species 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010046798 Uterine leiomyoma Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023799 Large intestinal ulcer Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000223794 Paramecium aurelia Species 0.000 description 1
- 241001279233 Paramecium bursaria Species 0.000 description 1
- 241001649226 Paramecium calkinsi Species 0.000 description 1
- 241000178302 Paramecium multimicronucleatum Species 0.000 description 1
- 241001559018 Paramecium polycaryum Species 0.000 description 1
- 241000532144 Paramecium woodruffi Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000010579 uterine corpus leiomyoma Diseases 0.000 description 1
- 201000007954 uterine fibroid Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Seeds, Soups, And Other Foods (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10485279A JPS5629520A (en) | 1979-08-17 | 1979-08-17 | Nutrient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10485279A JPS5629520A (en) | 1979-08-17 | 1979-08-17 | Nutrient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5629520A JPS5629520A (en) | 1981-03-24 |
| JPS6323972B2 true JPS6323972B2 (enExample) | 1988-05-18 |
Family
ID=14391812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10485279A Granted JPS5629520A (en) | 1979-08-17 | 1979-08-17 | Nutrient |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5629520A (enExample) |
-
1979
- 1979-08-17 JP JP10485279A patent/JPS5629520A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5629520A (en) | 1981-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
| CN105687285A (zh) | 一种熏香及其制备方法 | |
| WO2015176558A1 (zh) | 一种天然维生素c和鱼鳞胶原蛋白肽的组合物及其制备方法 | |
| CN102743741A (zh) | 蟑螂多肽的制备及其抗革兰氏阳性及阴性菌医药用途 | |
| TW200826953A (en) | Agonist for healing living organisms | |
| CN106074493A (zh) | 一种大麻提取物在制备治疗痛风性关节炎药物中的应用 | |
| CN106074463A (zh) | 大麻二酚在制备治疗痛风性关节炎药物中的应用 | |
| JP2023505620A (ja) | 漢方薬組成物及びその製造方法並びに使用 | |
| CN121197377A (zh) | 一种改善血管栓塞的地龙蛋白肽组合物及其制备方法 | |
| US7780992B2 (en) | Antiviral medicament | |
| TWI336624B (en) | Use of a potent product extracted from rhizomes of zingiber officinale in treating a disease associated with helicobacter pylori | |
| CN106074464A (zh) | 大麻二酚在制备治疗痛风药物中的应用 | |
| CN106539804A (zh) | 一种用于缓解骨关节炎疼痛的分子中药霜剂及其制备方法 | |
| CN106362125A (zh) | 一种保健足贴及其使用方法 | |
| CN110478235A (zh) | 一种腹泻灸及其制备方法 | |
| CN117357547A (zh) | 一种药物组合物在制备治疗类风湿关节炎药物中的用途 | |
| CN1650846B (zh) | 榄香烯脂质体及其制备方法 | |
| CN117797217A (zh) | 一种速愈治疗皮肤病的中药外用喷剂 | |
| CN104546822A (zh) | 淫羊藿苷元的医药用途 | |
| JPH04243834A (ja) | 免疫力増強・体質改善剤の製造法 | |
| JP6231895B2 (ja) | 化粧料、化粧料の製造方法、皮膚外用剤、及び皮膚外用剤の製造方法 | |
| CN111317809A (zh) | 一种骆驼峰复合油膏及其制备方法和应用 | |
| CN106668131A (zh) | 一种地龙组合物及其制备方法 | |
| JPS629567B2 (enExample) | ||
| CN1762341A (zh) | 治疗心脑血管疾病、肝脏疾病的丹参酚酸复合物及其应用 |